Skip to content

The cost-effectiveness of fatigue management in patients with Inflammatory Bowel Disease (IBD)

The cost-effectiveness of fatigue management in patients with Inflammatory Bowel Disease (IBD) - The cost-effectiveness of fatigue management.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34314
Enrollment
126
Registered
2010-07-14
Start date
2010-08-14
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatigue tiredness

Interventions

The training is Solution - Focused Cognitive Therapy (SFT). SFT is a brief psychological intervention based on the solution - focused model of solving problems. Although problems, in this study cau

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the fatigue group were: age > 18 years, remission of the disease (CDAI = 35).;Inclusion criteria for the non-fatigue group: age > 18 years, remission of the disease (CDAI

Exclusion criteria

Exclusion criteria: Exclusion criteria were: pregnancy; surgery within 3 months prior to this study, neoplastic condition; other gastrointestinal diseases; psychiatric disorder (Hospital Anxiety and Depression Scale (HADS) score > 10).

Design outcomes

Primary

MeasureTime frame
Aims of the study: 1. The primary aim of the study is improvement of fatigue and quality of life through the introduction of this specific coping strategy in IBD patients by performing a randomized controlled trial of Solution Focused Therapy.

Secondary

MeasureTime frame
1. Secondary aim is: to assess the cost-effectiveness of a fatigue coping course in patients with CD. 2. To investigate the mechanisms behind fatigue and the effects of psychological intervention on several cytokines known to be involved in IBD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)